ECM1 and colorectal carcinoma: IHC scores were then employed to evaluate the association between ECM1 expression and CRC patient clinicopathological features, revealing the expression of ECM1 to be significantly associated with CRC patient TNM staging (P<0.001), lymph node metastasis (P<0.001), and tumor size (P<0.05) (Tables 2, 3).